Tamer Takmaz

Tamer Takmaz

Auto-generated profile, based on publicly available information

Tamer Takmaz

Department of Ophthalmology, Ataturk Training and Research Hospital, Ankara - Turkey

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2010 in Current Eye Research
Verified
Journal Article
Closed access
PDF file
CGCanan Gürdal
Canan Gürdal
ÖSÖzge Saraç
Özge Saraç
IGİpEk Genç
İpEk Genç
HKHale Kırımlıoğlu
Hale Kırımlıoğlu
TTTamer Takmaz
Tamer Takmaz
ICİzZet Can
İzZet Can
Purpose: To evaluate the tear function tests and the ocular surface damage in Graves’ disease (GD) patients either with or without thyroid associated orbitopathy (TAO). Methods: Forty-two eyes of 21 randomly selected patients with GD, and 30 eyes of 15 healthy subjects were included in this prospective study. The presence of TAO was evaluated clinically. The palpebral fissure height, degree of proptosis, ocular surface disease index (OSDI), Schirmer tear test, tear break-up time (TBUT), and conjunctival impression cytology were assessed. The results were first compared between the patient and the control groups. Results were then compared between the patients with TAO (group I) and without TAO (group II). Results: The mean OSDI score in the patient group was 44.79 ± 11.83 and it was 21.17 ± 9.89 in the control group (p = 0.001). The mean Schirmer tear test score was 14.4 ± 8.32 mm and 24.9 ± 3.57 mm in the patient and control group, respectively (p = 0.001). The mean TBUT in the patient group was 7.1 sec. In the control group it was significantly increased to 10 sec (p = 0.003). The mean proptosis and interpalpebral distance did not show any difference between the GD patients and controls (p > 0.05). The patients with GD showed significant ocular surface damage in which 75.71% had grade 2–3 squamous metaplasia in temporal interpalpebral conjunctiva. Twenty-four (57%) eyes composed group I. There were no differences in the mean OSDI score, Schirmer tear test score, TBUT, and the amount of ocular surface damage between group I and group II (p > 0.05). Conclusions: Dry eye findings and the ocular surface damage in GD were most likely associated with the ocular surface inflammation. Before the development of the classic findings of TAO, ocular surface inflammation can be the only presenting clinical sign in GD.

26 August 2010 in Current Eye Research
Verified
Journal Article
Closed access
PDF file
CGCanan Gürdal
Canan Gürdal
IGİpek Genç
İpek Genç
ÖSÖzge Saraç
Özge Saraç
IGİpek Gönül
İpek Gönül
TTTamer Takmaz
Tamer Takmaz
ICİzzet Can
İzzet Can
Objectives: To evaluate the effects of topical cyclosporine A (CsA) 0.05% (Restasis) on the signs and symptoms of dry eye, on apoptosis, and on MMP-9 expression in conjunctiva epithelial cells in thyroid orbitopathy (TO)-related dry eye patients. Methods: Prospective, clinical study. Twenty-four eyes of 12 consecutive TO patients with dry eye findings instilled CsA twice daily for 2 months. Ocular surface disease index, Schirmer tear test, tear breakup time (TBUT), conjunctival apoptosis index, and conjunctival MMP-9 expression were evaluated before and after 2 months treatment. Conjunctival biopsies were harvested from all eyes at baseline and after 2 months treatment. Apoptosis was detected by the terminal deoxynucleotidyl transferase-mediated dUTP-nick end labeling (TUNEL) assay. MMP-9 expression was determined by immunohistochemistry. Results: After 2 months of topical CsA treatment, the mean OSDI score was significantly decreased from 58.08 ± 6.28 to 36.41 ± 11.75 (P = 0.001). At baseline, the mean Schirmer tear test score was 8.92 ± 5.52 mm. It was increased to 11.25 ± 4.71 mm after treatment (P > 0.05). The mean TBUT increased significantly from 3.92 ± 2.18 sec to 9.16 ± 3.34 sec (P = 0.001). The mean percentage of apoptosis index at baseline was 72.10 ± 35.82%. This was significantly decreased to 53.29 ± 34.46% after treatment (P = 0.008). The mean percentage of MMP-9 expression of the conjunctival epithelial cells was significantly decreased from 48.12 ± 28.58% to 26.66 ± 25.13% following treatment (P = 0.005). Conclusions: Topical CsA treatment appears to improve the signs and symptoms of dry eye and inhibits apoptosis and MMP-9 expression in conjunctival epithelial cells in TO-related dry eye patients after 2 months of treatment.

1 May 2010 in Journal of Cataract & Refractive Surgery
Verified
Journal Article
Closed access
ICİzZet Can
İzZet Can
TTTamer Takmaz
Tamer Takmaz
YYYelda Yıldız
Yelda Yıldız
HBHasan Ali Bayhan
Hasan Ali Bayhan
GSGülizar Soyugelen
Gülizar Soyugelen
BBBaşak Bostancı
Başak Bostancı
To compare the intraoperative and postoperative results of 3 phacoemulsification techniques. Atatürk Training and Research Hospital, 2nd Ophthalmology Department, Ankara, Turkey. In this prospective randomized study, patients had standard coaxial (2.8 mm incisions), microcoaxial (2.2 mm incisions), or biaxial microincision (1.2 to 1.4 mm trapezoidal incisions) phacoemulsification. Intraoperative phaco parameters and total surgical time were measured and complications recorded. Postoperative visual acuity improvement, pachymetric differences, and surgically induced astigmatism (SIA) results were compared. Each group comprised 45 eyes. There were no significant differences between the 3 groups in demographic, morphologic, or preoperative surgical data. The mean effective phaco time was 2.56 seconds +/- 2.46 (SD) in the standard coaxial group, 1.98 +/- 1.91 seconds in the microcoaxial group, and 1.29 +/- 1.85 seconds in the biaxial microincision group (P<.05). The mean total surgical time was 14.48 +/- 4.21 minutes, 13.01 +/- 3.66 minutes, and 18.79 +/- 6.58 minutes, respectively (P<.01), and the mean measured final incision size was 2.83 +/- 0.11 mm, 2.26 +/- 0.07 mm, and 1.89 +/- 0.21 mm, respectively. The mean SIA 90 days postoperatively was 0.46 diopter (D), 0.24 D, and 0.13 D, respectively (P<.01). There was no statistically significant difference in the complication rate, visual acuity gain, or pachymetric change between the groups (P>.05). All 3 techniques were reliable, functional, and effective, yielding good visual outcomes and low phaco parameters and complication rates. Biaxial microincision surgery, with the smallest incisions, induced less astigmatism and reduced all intraoperative phaco parameters except total surgical time.

1 November 2007 in European Journal of Ophthalmology
Verified
Journal Article
Closed access
PDF file
TTT. Takmaz
T. Takmaz
ICİ. Can
İ. Can
Purpose: To evaluate the intraoperative findings, complication rates, effect of intracameral adrenaline, and incidence of intraoperative floppy iris syndrome (IFIS) in patients using tamsulosin. Methods: In this prospective nonrandomized observational study, 858 eyes of 774 patients who had phacoemulsification between August 2005 and November 2006 were evaluated. Duration and preoperatively discontinuing time of tamsulosin intake were questioned. Preoperative pupil size, intraoperative iris behavior, progressive miosis, adrenalin usage, and complications were recorded. Results: The incidence of IFIS was 1.6% and IFIS was seen in 14 of the 18 eyes of patients using tamsulosin (77.8%). One eye had floppy iris only, 2 eyes had floppy iris and intraoperative miosis, 3 eyes had floppy iris and iris prolapse, and 8 eyes had all three signs of IFIS. IFIS was seen in 7 of the 10 eyes where intracameral adrenaline was used, and in 7 of the 8 eyes without adrenaline (p=0.588). Intraoperative miosis was seen only in 3 of the 10 eyes with adrenaline and in 7 of the 8 eyes without adrenaline (p=0.025). Posterior capsule rupture occurred in 1 of the eyes with IFIS and in 5 eyes focal iris stromal atrophy caused by prolapse was seen. Conclusions: IFIS occurred in 1.6% of cases having phacoemulsification. Intracameral adrenaline usage did not change the IFIS occurrence rate, but it seemed to be effective in preventing intraoperative miosis. There are still many questions about IFIS, and there is need for future studies strengthening the understanding of IFIS.

1 March 2004 in Journal of Cataract & Refractive Surgery
Verified
Journal Article
Closed access
ICIi̇zZet Can
Ii̇zZet Can
TTTamer Takmaz
Tamer Takmaz
FÇFerda Çakici
Ferda Çakici
MÖMeltem Özgül
Meltem Özgül
To compare intraoperative and postoperative effects of Nagahara phaco-chop and stop-and-chop phacoemulsification nucleotomy techniques. Department of Ophthalmology, SBMU First Aid and Traumatology Hospital, Ankara, Turkey. Seventy patients were evaluated prospectively in 2 groups. The Nagahara phaco-chop nucleotomy technique was performed in Group 1 (35 eyes) and the stop-and-chop technique in Group 2 (35 eyes). There were no significant between-group differences. The mean phaco time, phaco power, effective phaco time, time to achieve maximum vision, corneal thickness increase relative to the preoperative values, and time to return to the preoperative values were determined. All parameters in both groups were statistically compared using the chi-square test and the independent-samples t test. The mean phaco time was 1.3 minutes +/- 0.7 (SD), phaco power was 16.7% +/- 5.0%, and effective phaco time was 14.9 +/- 11.8 seconds in Group 1 and 1.8 +/- 0.9 minutes, 20.0% +/- 6.2%, and 22.3 +/- 14.2 seconds, respectively, in Group 2. The mean time to achieve maximum vision postoperatively was 6.9 +/- 3.7 days in Group 1 and 11.7 +/- 7.7 days in Group 2. The mean postoperative corneal thickness increase in Group 1 and Group 2 was 52.3 +/- 84.5 microm and 111.6 +/- 151.2 microm, respectively, and the mean time to return to preoperative pachymetry values, 9.8 +/- 5.7 days and 13.7 +/- 10.0 days, respectively. There were significant between-group differences in these parameters. The Nagahara phaco-chop technique had fewer negative effects on the corneal endothelium as less ultrasonic energy was used. This accelerated the functional healing process and the return to preoperative physiologic values.

18 June 2015
Verified
Journal Article
Open access
AAAysegul Arman
Aysegul Arman
DDDuriye Deniz Demirseren
Duriye Deniz Demirseren
TTTamer Takmaz
Tamer Takmaz
To compare the effectiveness of topical cyclosporine A emulsion with that of oral doxycycline for rosacea associated ocular changes and dry eye complaints. One hundred and ten patients with rosacea were screened. Thirty-eight patients having rosacea associated eyelid and ocular surface changes and dry eye complaints were included in the study. Patients were randomly divided into two groups: nineteen patients were given topical cyclosporine twice daily and nineteen patients were given oral doxycycline 100 mg twice daily for the first month and once daily for the following two months. Symptom and sign scores, ocular surface disease index questionnarie and tear function tests were evaluated at baseline and monthly for 3mo. Three months after results were compared with that of baseline. Mean values of symptom, eyelid sign and corneal/conjunctival sign scores of each treatment group at baseline and 3mo after treatments were compared and both drugs were found to be effective on rosacea associated ocular changes (P<0.001). Cyclosporine was more effective in symptomatic relief and in the treatment of eyelid signs (P=0.01). There was statistically significant increase in the mean Schirmer score with anesthesia and tear break up time scores in the cyclosporine treatment group compared to the doxycycline treatment group (P<0.05). Cyclosporine as a topical drug can be used in the treatment of rosacea associated ocular complications because it is more effective than doxycycline. In addition ocular rosacea as a chronic disease requires long term treatment and doxycycline has various side effects limiting its long term usage.